Skip to main content
Top
Published in: Chinese Medicine 1/2022

Open Access 01-12-2022 | Pulmonary Edema | Research

Combination of pseudoephedrine and emodin ameliorates LPS-induced acute lung injury by regulating macrophage M1/M2 polarization through the VIP/cAMP/PKA pathway

Authors: Wen-Ba Wang, Jing-Tao Li, Yi Hui, Jie Shi, Xu-Yan Wang, Shu-Guang Yan

Published in: Chinese Medicine | Issue 1/2022

Login to get access

Abstract

Background

Acute lung injury (ALI) is an acute multifactorial infectious disease induced by trauma, pneumonia, shock, and sepsis. This study aimed to investigate the protective effects of pseudoephedrine and emodin combined treatment in experimental ALI, as well as the mechanisms underlying the regulation of inflammation and pulmonary edema via the VIP/cAMP/PKA pathway.

Methods

The wistar rats were randomly divided into fifteen groups (n = 5). Rats in each group were given intragastric administration 1 h before LPS injection. Those in the control and LPS groups were given intragastric administrations of physiological saline, rats in other groups were given intragastrically administered of differential dose therapeutic agents. The rats in the LPS and treatment groups were then injected intraperitoneally with LPS (7.5 mg/kg) to induce ALI. After being treated with pseudoephedrine and emodin for 12 h, all animals were sacrifice. Anal temperatures were taken on an hourly basis for 8 h after LPS injection. Pathological examination of lung specimen was performed by H&E staining. Cytokines (IL-1β, TNF-α, IL-6, iNOS, IL-10, Arg-1, CD86, CD206, F4/80, VIP) in lung tissue were assayed by ELISA and immunofluorescence. The expression of VIP, CAMP, AQP-1, AQP-5, p-PKA, PKA, p-IκBα, IκBα, p-p65, p65, p-P38, P38, p-ERK1/2, ERK1/2, p-JNK1/2, JNK1/2 protein in lung was determined by western blotting.

Results

After rats being treated with pseudoephedrine + emodin, reduced of fever symptoms. The contents of inflammatory cytokines (IL-1β, TNF-α, IL-6, iNOS) were decreased and anti-inflammatory cytokines (IL-10, Arg-1) were significantly increased in serum. Pseudoephedrine + emodin treatment effectively promoted VIP cAMP and p-PKA protein expression in lung tissues, and significantly inhibited NF-κB, MAPK phosphorylation, Pseudoephedrine + emodin treatment can inhibit M1 polarization and promoted M2 polarization via the VIP/cAMP/PKA signaling pathway.

Conclusions

The combination of Pseudoephedrine and emodin was effective in ameliorating LPS-induced ALI in rats by inducing VIP/cAMP/PKA signaling. Inhibiting the NF-κB, MAPK inflammatory pathway, relief of pulmonary edema suppressing macrophage M1 polarization, and promoting macrophage M2 polarization.
Literature
1.
go back to reference Gupta N, Su X, Popov B, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin induced acute lung injury in mice. J Immunol. 2007;179:1855–63.CrossRef Gupta N, Su X, Popov B, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin induced acute lung injury in mice. J Immunol. 2007;179:1855–63.CrossRef
2.
go back to reference Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–49.CrossRef Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–49.CrossRef
3.
go back to reference Derwall M, Martin L, Rossaint R. The acute respiratory distress syndrome: pathophysiology, current clinical practice, and emerging therapies. Expert Rev Respir Med. 2018;12:1021–9.CrossRef Derwall M, Martin L, Rossaint R. The acute respiratory distress syndrome: pathophysiology, current clinical practice, and emerging therapies. Expert Rev Respir Med. 2018;12:1021–9.CrossRef
4.
go back to reference Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5:18.CrossRef Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5:18.CrossRef
5.
go back to reference Shi DF, Zheng MZ, Wang YM, et al. Protective effects and mechanisms of mogroside V on LPS-induced acute lung injury in mice. Pharm Biol. 2014;52:729–34.CrossRef Shi DF, Zheng MZ, Wang YM, et al. Protective effects and mechanisms of mogroside V on LPS-induced acute lung injury in mice. Pharm Biol. 2014;52:729–34.CrossRef
6.
go back to reference Karpurapu M, Lee YG, Qian Z, Wen J, et al. Inhibition of nuclear factor of activated T cells (NFAT) c3 activation attenuates acute lung injury and pulmonary edema in murine models of sepsis. Oncotarget. 2018;9:10606–20.CrossRef Karpurapu M, Lee YG, Qian Z, Wen J, et al. Inhibition of nuclear factor of activated T cells (NFAT) c3 activation attenuates acute lung injury and pulmonary edema in murine models of sepsis. Oncotarget. 2018;9:10606–20.CrossRef
7.
go back to reference Liu W, Liu K, Zhang S, et al. Tetramethylpyrazine showed therapeutic effects on sepsis-induced acute lung injury in rats by inhibiting endoplasmic reticulum stress protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling-induced apoptosis of pulmonary microvascular endothelial cells. Med Sci Monit. 2018;24:1225–31.CrossRef Liu W, Liu K, Zhang S, et al. Tetramethylpyrazine showed therapeutic effects on sepsis-induced acute lung injury in rats by inhibiting endoplasmic reticulum stress protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling-induced apoptosis of pulmonary microvascular endothelial cells. Med Sci Monit. 2018;24:1225–31.CrossRef
8.
go back to reference Huang X, Zeng Y, Jiang Y, et al. Lipopolysaccharide–binding protein downregulates fractalkine through activation of p38 MAPK and NF-Κb. Mediators Inflamm. 2017;2017:9734837.PubMedPubMedCentral Huang X, Zeng Y, Jiang Y, et al. Lipopolysaccharide–binding protein downregulates fractalkine through activation of p38 MAPK and NF-Κb. Mediators Inflamm. 2017;2017:9734837.PubMedPubMedCentral
10.
go back to reference Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2019;15:1–25. Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2019;15:1–25.
11.
12.
go back to reference Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA, J Am Med Assoc. 2019;324:782–93.CrossRef Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA, J Am Med Assoc. 2019;324:782–93.CrossRef
13.
go back to reference Onoue S, Matsui T, Kato M, Mizumoto T, et al. Chemical synthesis and formulation design of a PEGylated vasoactive intestinal peptide derivative with improved metabolic stability. Eur J Pharm Sci. 2013;49:382–9.CrossRef Onoue S, Matsui T, Kato M, Mizumoto T, et al. Chemical synthesis and formulation design of a PEGylated vasoactive intestinal peptide derivative with improved metabolic stability. Eur J Pharm Sci. 2013;49:382–9.CrossRef
14.
go back to reference Xu C, Wang Y, Sun R, Qiao X, et al. Modulatory effects of vasoactive intestinal peptide on intestinal mucosal immunity and microbial community of weaned piglets challenged by an enterotoxigenic Escherichia coli (K88). PLoS ONE. 2014;9:e104183.CrossRef Xu C, Wang Y, Sun R, Qiao X, et al. Modulatory effects of vasoactive intestinal peptide on intestinal mucosal immunity and microbial community of weaned piglets challenged by an enterotoxigenic Escherichia coli (K88). PLoS ONE. 2014;9:e104183.CrossRef
15.
go back to reference Laube BL. Aerosolized medications for gene and peptide therapy. Respir Care. 2015;60:806–21 (discussion 821-4).CrossRef Laube BL. Aerosolized medications for gene and peptide therapy. Respir Care. 2015;60:806–21 (discussion 821-4).CrossRef
16.
go back to reference Pearce L, Komander D, Alessi D, Alessi DR. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol. 2010;11:9–22.CrossRef Pearce L, Komander D, Alessi D, Alessi DR. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol. 2010;11:9–22.CrossRef
17.
go back to reference Gancedo JM. Biological roles of cAMP: variations on a theme in the different kingdoms of life. Biol Rev. 2013;88:645–68.CrossRef Gancedo JM. Biological roles of cAMP: variations on a theme in the different kingdoms of life. Biol Rev. 2013;88:645–68.CrossRef
18.
go back to reference Soni M, Carabin I, Griffiths JC, Burdock G. Safety of ephedra: lessons learned. Toxicol Lett. 2004;150:97–110.CrossRef Soni M, Carabin I, Griffiths JC, Burdock G. Safety of ephedra: lessons learned. Toxicol Lett. 2004;150:97–110.CrossRef
19.
go back to reference Lin YC, Chang CW, Wu CR. Antitussive, anti-pyretic and toxicological evaluation of Ma-Xing-Gan-Shi-Tang in rodents. BMC Complement Altern Med. 2016;16:456.CrossRef Lin YC, Chang CW, Wu CR. Antitussive, anti-pyretic and toxicological evaluation of Ma-Xing-Gan-Shi-Tang in rodents. BMC Complement Altern Med. 2016;16:456.CrossRef
20.
go back to reference Ma LQ, Pan CS, Yang N, Liu YY, et al. Posttreatment with Ma-Xing-Shi-Gan-Tang, a Chinese medicine formula, ameliorates lipopolysaccharide-induced lung microvessel hyperpermeability and inflammatory reaction in rat. Microcirculation. 2014;21:649–63.CrossRef Ma LQ, Pan CS, Yang N, Liu YY, et al. Posttreatment with Ma-Xing-Shi-Gan-Tang, a Chinese medicine formula, ameliorates lipopolysaccharide-induced lung microvessel hyperpermeability and inflammatory reaction in rat. Microcirculation. 2014;21:649–63.CrossRef
21.
go back to reference Li P, Zhang J, Liang X. Characterization of the complete chloroplast genome of Ephedra sinica Stapf (Ephedraceae), a traditional Chinese medicine. Mitochondrial DNA B Resour. 2019;4:3301–2.CrossRef Li P, Zhang J, Liang X. Characterization of the complete chloroplast genome of Ephedra sinica Stapf (Ephedraceae), a traditional Chinese medicine. Mitochondrial DNA B Resour. 2019;4:3301–2.CrossRef
22.
go back to reference Głowacka K, Wiela-Hojeńska A. Pseudoephedrine-benefits and risks. Int J Mol Sci. 2021;22:5146.CrossRef Głowacka K, Wiela-Hojeńska A. Pseudoephedrine-benefits and risks. Int J Mol Sci. 2021;22:5146.CrossRef
23.
go back to reference Wellington K, Jarvis B. Cetirizine/pseudoephedrine. Drugs. 2001;61:2231–40 (discussion 2241-2).CrossRef Wellington K, Jarvis B. Cetirizine/pseudoephedrine. Drugs. 2001;61:2231–40 (discussion 2241-2).CrossRef
24.
go back to reference LaForce C, Gentile DA, Skoner DP. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/Pseudoephedrine for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections. Postgrad Med. 2008;120:53–9.CrossRef LaForce C, Gentile DA, Skoner DP. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/Pseudoephedrine for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections. Postgrad Med. 2008;120:53–9.CrossRef
25.
go back to reference Dong X, Fu J, Yin X, Cao S, Li X, Huyiligeqi LL, Ni J. Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytother Res. 2016;30:1207–18.CrossRef Dong X, Fu J, Yin X, Cao S, Li X, Huyiligeqi LL, Ni J. Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytother Res. 2016;30:1207–18.CrossRef
26.
go back to reference Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW, Crystal RG. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis. 1979;120:893–9.PubMed Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW, Crystal RG. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis. 1979;120:893–9.PubMed
27.
go back to reference Lu Y, Jiang Y, Ling L, Zhang Y, Li H, Chen D. Beneficial effects of Houttuynia cordata polysaccharides on “two-hit” acute lung injury and endotoxic fever in rats associated with anti-complementary activities. Acta Pharm Sin B. 2018;8:218–27.CrossRef Lu Y, Jiang Y, Ling L, Zhang Y, Li H, Chen D. Beneficial effects of Houttuynia cordata polysaccharides on “two-hit” acute lung injury and endotoxic fever in rats associated with anti-complementary activities. Acta Pharm Sin B. 2018;8:218–27.CrossRef
28.
go back to reference Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349–61.CrossRef Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349–61.CrossRef
29.
go back to reference Lv H, Liu Q, Wen Z, et al. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis. Redox Biol. 2017;12:311–24.CrossRef Lv H, Liu Q, Wen Z, et al. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis. Redox Biol. 2017;12:311–24.CrossRef
30.
go back to reference Raina S. Molecular cloning and characterization of an aquaporin cDNA from salivary, lacrimal, and respiratory tissues. J Biol Chem. 1995;270:1908–12.CrossRef Raina S. Molecular cloning and characterization of an aquaporin cDNA from salivary, lacrimal, and respiratory tissues. J Biol Chem. 1995;270:1908–12.CrossRef
31.
go back to reference Fairweather D, Rose NR. Inflammatory heart disease: a role for cytokines. Lupus. 2005;14:646–51.CrossRef Fairweather D, Rose NR. Inflammatory heart disease: a role for cytokines. Lupus. 2005;14:646–51.CrossRef
32.
go back to reference Murakami A, Ohigashi H. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer. 2007;121:2357–63.CrossRef Murakami A, Ohigashi H. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer. 2007;121:2357–63.CrossRef
33.
go back to reference Quinton LJ, Walkey AJ, Mizgerd JP. Integrative physiology of Pneumonia. Physiol Rev. 2018;98:1417–64.CrossRef Quinton LJ, Walkey AJ, Mizgerd JP. Integrative physiology of Pneumonia. Physiol Rev. 2018;98:1417–64.CrossRef
34.
go back to reference Zhou Y, Zhang CY, Duan JX, et al. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages. Biomed Pharmacother. 2019;121:109596.CrossRef Zhou Y, Zhang CY, Duan JX, et al. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages. Biomed Pharmacother. 2019;121:109596.CrossRef
35.
go back to reference Ramhorst R, Calo G, Paparini D, et al. Control of the inflammatory response during pregnancy: potential role of VIP as a regulatory peptide. Ann N Y Acad Sci. 2019;1437:15–21.CrossRef Ramhorst R, Calo G, Paparini D, et al. Control of the inflammatory response during pregnancy: potential role of VIP as a regulatory peptide. Ann N Y Acad Sci. 2019;1437:15–21.CrossRef
36.
go back to reference Grebe A, Hoss F, Latz E. NLRP3 inflammasome and the IL-1 pathway in atherosclerosis. circ res. 2018;122:1722–40.CrossRef Grebe A, Hoss F, Latz E. NLRP3 inflammasome and the IL-1 pathway in atherosclerosis. circ res. 2018;122:1722–40.CrossRef
37.
go back to reference Kang JL, Lee HW, Lee HS, Pack IS, Chong Y, Castranova V, Koh Y. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med. 2001;164:2206–12.CrossRef Kang JL, Lee HW, Lee HS, Pack IS, Chong Y, Castranova V, Koh Y. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med. 2001;164:2206–12.CrossRef
38.
go back to reference Tate MD, Mansell A. An update on the NLRP3 inflammasome and influenza: the road to redemption or perdition? Curr Opin Immunol. 2018;54:80–5.CrossRef Tate MD, Mansell A. An update on the NLRP3 inflammasome and influenza: the road to redemption or perdition? Curr Opin Immunol. 2018;54:80–5.CrossRef
39.
go back to reference Carrión M, Pérez-García S, Martínez C, et al. VIP impairs acquisition of the macrophage proinflammatory polarization profile. J Leukoc Biol. 2016;100:1385–93.CrossRef Carrión M, Pérez-García S, Martínez C, et al. VIP impairs acquisition of the macrophage proinflammatory polarization profile. J Leukoc Biol. 2016;100:1385–93.CrossRef
40.
go back to reference Xu Y, Zhang R, Li C, Yin X, Lv C, Wang Y, Zhao W, Zhang X. Dexmedetomidine attenuates acute lung injury induced by lipopolysaccharide in mouse through inhibition of MAPK pathway. Fundam Clin Pharmacol. 2015;29:462–71.CrossRef Xu Y, Zhang R, Li C, Yin X, Lv C, Wang Y, Zhao W, Zhang X. Dexmedetomidine attenuates acute lung injury induced by lipopolysaccharide in mouse through inhibition of MAPK pathway. Fundam Clin Pharmacol. 2015;29:462–71.CrossRef
41.
go back to reference Xie X, Sun S, Zhong W, Soromou LW, Zhou X, Wei M, Ren Y, Ding Y. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol. 2014;19:103–9.CrossRef Xie X, Sun S, Zhong W, Soromou LW, Zhou X, Wei M, Ren Y, Ding Y. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol. 2014;19:103–9.CrossRef
Metadata
Title
Combination of pseudoephedrine and emodin ameliorates LPS-induced acute lung injury by regulating macrophage M1/M2 polarization through the VIP/cAMP/PKA pathway
Authors
Wen-Ba Wang
Jing-Tao Li
Yi Hui
Jie Shi
Xu-Yan Wang
Shu-Guang Yan
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Chinese Medicine / Issue 1/2022
Electronic ISSN: 1749-8546
DOI
https://doi.org/10.1186/s13020-021-00562-8

Other articles of this Issue 1/2022

Chinese Medicine 1/2022 Go to the issue